TOP > News Release > Capital Alliance between Otsuka Pharmaceutical Factory and Neuroceuticals

January 14, 2022

Capital Alliance between Otsuka Pharmaceutical Factory and Neuroceuticals

Otsuka Pharmaceutical Factory, Inc. (Head Office: Naruto, Tokushima, Japan; President and Representative Director: Shinichi Ogasawara; "OPF") has invested in and taken a stake in a medical device venture company Neuroceuticals, Inc. (Head Office: Bunkyo-ku, Tokyo, Japan; President and Representative Director: Shinya Miike; "NCI").

OPF and NCI have been working together since 2019 to develop advanced medical devices, and now OPF has invested in NCI to further strengthen these efforts. We intend to advance the development of innovative medical devices that solve the challenges of various clinical needs in clinical practice, and work together to provide better medical care.

[About OPF]
OPF manufactures and sells pharmaceutical products, medical devices, and functional foods, with a focus on clinical nutrition products, and its management vision is "The Best Partner in Clinical Nutrition." With this investment, OPF aims to develop advanced medical devices that can only be achieved by a company that has strengths in the area of clinical nutrition.

[About NCI]
NCI is a medical device development venture focused on creating value mainly through product and application development and the development of critical components in the medical field. NCI also uses its own marketing network to search for needs focusing on equipment that doctors need, equipment that enables more efficient diagnosis and treatment, and equipment that enhances the quality of life of patients, and releases products, including those procured overseas.